We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01470443
Recruitment Status : Unknown
Verified May 2019 by Ho Yeong Lim, Samsung Medical Center.
Recruitment status was:  Active, not recruiting
First Posted : November 11, 2011
Last Update Posted : May 21, 2019
Information provided by (Responsible Party):
Ho Yeong Lim, Samsung Medical Center